Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asthma Atopic”

392 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 392 results

Large-scale testing (Phase 3)Study completedNCT01155700
What this trial is testing

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 51
Post-approval studies (Phase 4)Study completedNCT00639691
What this trial is testing

A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy

Who this might be right for
Asthma
Novartis 48
Not applicableUnknownNCT03915197
What this trial is testing

Acute Bronchiolitis in Infants and Allergic Asthma

Who this might be right for
Acute BronchiolitisAsthmaAllergy
University Hospital, Clermont-Ferrand 320
Early research (Phase 1)Study completedNCT01577953
What this trial is testing

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

Who this might be right for
Asthma
Sterna Biologicals GmbH & Co. KG 24
Testing effectiveness (Phase 2)Study completedNCT00394654
What this trial is testing

Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma

Who this might be right for
Asthma
MedImmune LLC 30
Testing effectiveness (Phase 2)Study completedNCT01501942
What this trial is testing

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

Who this might be right for
Asthma
AIM Therapeutics Inc. 11
Testing effectiveness (Phase 2)Study completedNCT01890161
What this trial is testing

A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma

Who this might be right for
Atopic Asthma
Axikin Pharmaceuticals, Inc. 21
Early research (Phase 1)Study completedNCT03138811
What this trial is testing

A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 28
Early research (Phase 1)Study completedNCT05803902
What this trial is testing

An Evaluation of 9MW1911 Injection in Healthy Subjects

Who this might be right for
AsthmaCOPDAtopic Dermatitis
Mabwell (Shanghai) Bioscience Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT05332067
What this trial is testing

Omalizumab Before Onset of Exacerbations

Who this might be right for
Asthma in ChildrenAtopyViral Upper Respiratory Infection
Children's National Research Institute 300
Testing effectiveness (Phase 2)Study completedNCT01607372
What this trial is testing

Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

Who this might be right for
Asthma and Rhinitis
GlaxoSmithKline 18
Not applicableEnded earlyNCT02636933
What this trial is testing

Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters

Who this might be right for
AsthmaAllergic Rhinitis
Stefania La Grutta, MD 152
Not applicableStudy completedNCT03480815
What this trial is testing

Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

Who this might be right for
Severe Allergic Asthma
Chang Gung Memorial Hospital 24
Early research (Phase 1)Ended earlyNCT06592768
What this trial is testing

A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma

Who this might be right for
Allergic Asthma
Jasper Therapeutics, Inc. 17
Not applicableStudy completedNCT01026506
What this trial is testing

C9,t11-CLA in Children and Adolescents With Allergic Asthma

Who this might be right for
Allergic Bronchial Asthma
University of Jena 29
Testing effectiveness (Phase 2)Ended earlyNCT00318747
What this trial is testing

Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

Who this might be right for
AsthmaAllergyAllergic Rhinitis+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 140
Large-scale testing (Phase 3)Study completedNCT00482248
What this trial is testing

Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

Who this might be right for
Asthma
Novartis 132
Not applicableWithdrawnNCT01002976
What this trial is testing

Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma

Who this might be right for
Severe Allergic Asthma
Carmel Medical Center
Not applicableStudy completedNCT02327234
What this trial is testing

Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma

Who this might be right for
Atopic Asthma
University of Saskatchewan 13
Post-approval studies (Phase 4)Study completedNCT00691873
What this trial is testing

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Next Page